Finding an effective therapy to treat chronic neurodegenerative disorders still represents an unmet and elusive goal, mainly because so many pathogenic variables come into play in these diseases. Recent emphasis has been placed on the role of neurotrophic factors in the aetiology of such disorders because of their role in the survival of different cell phenotypes under various adverse conditions, including neurodegeneration. This review summarizes the current status and the efforts to treat neurodegenerative disorders by the exogenous administration of neurotrophic factors in an attempt to replenish trophic supply, the paucity of which may contribute to the development of the illness. Although promising results have been seen in animal models, this approach still meets disparate and often insurmountable problems in clinical settings, presumably related to the unique nature of the human being

Neurotrophic factors in neurodegenerative disorders potential for therapy / F. Fumagalli, R. Molteni, F. Calabrese, P.F. Maj, G. Racagni, M.A. Riva. - In: CNS DRUGS. - ISSN 1172-7047. - 22:12(2008), pp. 1005-1019.

Neurotrophic factors in neurodegenerative disorders potential for therapy

F. Fumagalli
Primo
;
R. Molteni
Secondo
;
F. Calabrese;P.F. Maj;G. Racagni
Penultimo
;
M.A. Riva
Ultimo
2008

Abstract

Finding an effective therapy to treat chronic neurodegenerative disorders still represents an unmet and elusive goal, mainly because so many pathogenic variables come into play in these diseases. Recent emphasis has been placed on the role of neurotrophic factors in the aetiology of such disorders because of their role in the survival of different cell phenotypes under various adverse conditions, including neurodegeneration. This review summarizes the current status and the efforts to treat neurodegenerative disorders by the exogenous administration of neurotrophic factors in an attempt to replenish trophic supply, the paucity of which may contribute to the development of the illness. Although promising results have been seen in animal models, this approach still meets disparate and often insurmountable problems in clinical settings, presumably related to the unique nature of the human being
NERVE GROWTH-FACTOR ; AMYOTROPHIC-LATERAL-SCLEROSIS ; NEURAL STEM-CELLS ; FACTOR PREVENTS DEGENERATION ; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS ; CHOLINERGIC NEURONAL DEGENERATION ; NIGROSTRIATAL DOPAMINERGIC SYSTEM ; NEUROPROTECTIVE GENE-THERAPY ; REMITTING MULTIPLE-SCLEROSIS ; SUBSTANTIA-NIGRA NEURONS
Settore BIO/14 - Farmacologia
2008
http://cnsdrugs.adisonline.com/pt/re/cns/home.htm;jsessionid=J4hGtc14xQV1xVwZJ0r2GytQnKvc3thgs12hSQGvGvY8qMws1yv6!928310026!181195629!8091!-1
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/53498
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 33
social impact